Natco Pharma
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | Pharmaceuticals
 |
Half Yearly Results of Natco Pharma |
------------------- in Rs. Cr. ------------------- |
| Sep '07 | Mar '08 | Sep '08 | Mar '09 | Sep '09 | ||||||
| ||||||||||
|
||||||||||
| 6 mths | 6 mths | 6 mths | 6 mths | 6 mths | ||||||
|
||||||||||
| Sales Turnover | 111.81 | 116.07 | 118.70 | 167.37 | 152.64 | |||||
| Other Income | 7.72 | 15.03 | 12.16 | -12.16 | -- | |||||
| Total Income | 119.53 | 131.10 | 130.86 | 155.21 | 152.64 | |||||
| Total Expenses | 91.40 | 96.79 | 99.34 | 113.37 | 111.06 | |||||
| Operating Profit | 20.41 | 19.28 | 19.36 | 54.00 | 41.58 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | 1.14 | 8.06 | 2.96 | 1.18 | 0.16 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 28.13 | 34.31 | 31.52 | 41.84 | 41.58 | |||||
| Interest | 4.23 | 4.27 | 6.23 | 7.50 | 7.60 | |||||
| PBDT | 25.04 | 38.10 | 28.25 | 35.52 | 34.14 | |||||
| Depreciation | 4.90 | 3.69 | 5.55 | 4.80 | 6.45 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 20.14 | 34.41 | 22.70 | 30.72 | 27.69 | |||||
| Tax | 3.01 | 11.49 | 3.82 | 6.86 | 6.44 | |||||
| Net Profit | 17.13 | 22.92 | 18.88 | 23.86 | 21.25 | |||||
| Prior Year Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share(Rs) | 6.24 | 8.17 | 6.73 | 8.51 | 7.55 | |||||
| Book Value(Rs) | -- | -- | -- | -- | -- | |||||
| Equity | 27.47 | 28.04 | 28.04 | 28.04 | 28.15 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value(Rs) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Natco Pharma connections | ||||||||||
| ||||||||||
